PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

Condition:   Esophageal Cancer
Interventions:   Drug: Cyclophosphamide;   Drug: Interleukin-2;   Other: PD-1 Knockout T Cells
Sponsor:   Hangzhou Cancer Hospital
Not yet recruiting - verified March 2017

http://ift.tt/2nvEaFI